Showing posts with label AthenaHealth. Show all posts
Showing posts with label AthenaHealth. Show all posts

Monday, May 2, 2011

EPS Est. on (ATHN) (CVH) (EMN) (GT) Raised

AthenaHealth (NASDAQ: ATHN), Coventry Health Care, Inc. (NYSE: CVH), Eastman Chemical Co (NYSE: EMN) and Goodyear (NYSE: GT) get EPS estimates raised today.

Goldman Sachs (NYSE:GS) raised their EPS estimate on AthenaHealth (ATHN). They have a “neutral” rating and a price target of $47.00 on the company.

Goldman Sachs raised their EPS estimate on Coventry Health Care, Inc. (CVH). They have a “neutral” rating and a price target of $38.00 on the company.

Bank of America (NYSE:BAC) raised their EPS estimate on Eastman Chemical Co (EMN). They have a “buy” rating and a price target of $128.00 on the company.

Goldman Sachs raised their EPS estimate on Goodyear (GT). They now have a “neutral” rating and a price target of $20.00 on the company.

Wednesday, April 27, 2011

Medifast (MED) (ATHN) (GRT) LXRX) - New Ratings and Price Targets

New ratings and price targets on Medifast, Inc. (NYSE: MED), AthenaHealth (NASDAQ: ATHN), Glimcher Realty Trust (NYSE: GRT) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX).

Oppenheimer initiated coverage on AthenaHealth (ATHN). They placed an “Underperform” rating and a price target of $30.00 on the firm.

Goldman Sachs (NYSE:GS) initiated coverage on Glimcher Realty Trust (GRT). They placed a “Neutral” rating on the stock.

Wedbush initiated coverage on Lexicon Pharmaceuticals, Inc. (LXRX). They placed an “Outperform” rating and a price target of $3.00 on the company.

Capstone initiated coverage on Medifast, Inc. (MED). They placed a “Buy” rating on the shares.